Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Zurakowski, Ph.D.

Co-Author

This page shows the publications co-authored by David Zurakowski and Mark Gebhardt.
Connection Strength

0.404
  1. Unicameral bone cyst: a retrospective study of three surgical treatments. Clin Orthop Relat Res. 2008 Oct; 466(10):2519-26.
    View in: PubMed
    Score: 0.101
  2. Predicting fracture through benign skeletal lesions with quantitative computed tomography. J Bone Joint Surg Am. 2006 Jan; 88(1):55-70.
    View in: PubMed
    Score: 0.084
  3. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002 Jan; 84(1):49-57.
    View in: PubMed
    Score: 0.064
  4. Does CT-based Rigidity Analysis Influence Clinical Decision-making in Simulations of Metastatic Bone Disease? Clin Orthop Relat Res. 2016 Mar; 474(3):652-9.
    View in: PubMed
    Score: 0.043
  5. CT-based Structural Rigidity Analysis Is More Accurate Than Mirels Scoring for Fracture Prediction in Metastatic Femoral Lesions. Clin Orthop Relat Res. 2016 Mar; 474(3):643-51.
    View in: PubMed
    Score: 0.043
  6. Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis. Clin Cancer Res. 2015 Jun 01; 21(11):2514-9.
    View in: PubMed
    Score: 0.040
  7. Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine (Phila Pa 1976). 2002 Feb 15; 27(4):374-9.
    View in: PubMed
    Score: 0.016
  8. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop Relat Res. 2000 Apr; (373):11-7.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.